NKTR
Nektar Therapeutics · Healthcare
President and CEO Howard W Robin sold $29K of Nektar Therapeutics
Sold$29,086
$65.51Price
444Shares
−1%Stake
What NKTR did after the filing
- The stock from Fri, May 22 open, $68.00
- +5.7%
- S&P 500, same days
- −0.1%
Measured over 30 trading days, to the Jul 8 close.
Traded Tue, May 19. Filed Thu, May 21, 6:26 PM ET, after the close. Returns use the May 22 open and the Jul 8 close. Not investment advice.